FDA Cites Baxter’s Puerto Rico Facility for Long List of Violations

Drug Industry Daily
A A
The FDA hit a Baxter Healthcare sterile drug facility in Jayuya, Puerto Rico with a lengthy Form 483 listing numerous violations the agency observed in a Dec. 3-21, 2018 inspection.

To View This Article:

Login

Subscribe To Drug Industry Daily